Electrolyte C Equality is a powder specifically formulated to support electrolyte balance and replenish essential vitamins, ideal for animals in conditions of stress, dehydration or during phases of recovery from illness or intense physical effort.
The studied composition guarantees a rapid rebalancing action, promoting the maintenance of cellular functionality and energy recovery.
Its administration is simple and versatile, as the powder can easily be mixed with water or food, facilitating its intake even in the most difficult subjects.
Electrolyte C Equality helps to counteract electrolyte imbalances, preventing damage resulting from dehydration and facilitating the normal functioning of metabolic and muscular processes.
Therapeutic Indications
Electrolyte C Equality is indicated for the correction of electrolyte imbalances in animals subjected to conditions of physical stress, dehydration, diarrhea or high sweating. It is used to support during convalescence, phases of strong physical activity or environmental stress, as well as in cases of reduced food or water intake.
The powder acts effectively in restoring the normal concentration of mineral salts and fundamental vitamins, counteracting the negative effects of the loss of liquids and salts through urine, sweat or diarrhea. This supplement is particularly useful even in situations where the water balance is compromised, contributing to the rapid and safe replenishment of potassium, sodium, chlorine and vitamin C.
Regular use of Electrolyte C Equality promotes the functionality of the muscles and nervous system, strengthening the immune defenses thanks to the presence of vitamin C, which acts as an antioxidant and adjuvant in regenerative processes.
Furthermore, it is indicated to support animals of advanced age or with debilitating clinical conditions that can compromise energy assimilation and correct electrolyte balance, improving vitality and general resistance.
Composition
Active ingredients and components: Electrolyte C Equality contains a balanced mix of essential mineral salts such as sodium, potassium, chlorine, as well as a significant quantity of vitamin C. These elements are carefully dosed to ensure an effective synergistic action in restoring the natural levels of electrolytes and fundamental micronutrients.
The powder formulation allows rapid and complete assimilation, with selected excipients to maintain the stability of vitamin C and promote the solubility of the product in water or other liquids. It does not contain artificial additives or components that could alter the biological functionality of the active ingredients.
This composition guarantees the product excellent tolerability even in the case of prolonged administration, offering complete and balanced nutritional support without overloading the body with unnecessary elements.
Contraindications
Electrolyte C Equality must not be used in case of known hypersensitivity to one or more components of the formulation. Use is not recommended in animals with conditions of uncontrolled water retention or suffering from serious kidney pathologies that require specific restrictions in the intake of mineral salts.
It is recommended to consult a veterinarian before starting administration, especially in subjects with chronic pathologies or being treated with other drugs, to avoid possible interactions or specific contraindications linked to the clinical picture of the animal.
Furthermore, excessive intake of electrolyte supplements without correct evaluation can cause organic imbalances and overloads, therefore the dose and duration of administration must be scrupulously respected according to the indications of the veterinary professional.
Safety of the drug for the species
Electrolyte C Equality is formulated to be safe and well tolerated in the animal species for which it is intended. The presence of vitamins and mineral salts in balanced doses ensures effective integration without causing negative effects or toxicity, when used correctly.
It is important that use is carried out in accordance with the therapeutic indications to prevent any associated risks
